A Deep Blue Wave is Rising, and Establishment Democrats are Panicking
“Frankly, if I was Mark Zuckerberg I Would be Absolutely Ecstatic at a Chance to do Something Helpful for Someone in Need and Maybe get Some Good PR out of it”
A Meta Employee Asked for More Time Off. CTO Andrew Bosworth Called the Question ‘Very Dumb’
Trump’s Approval Rating has Declined Over the Course of This Administration. It’s now Comparable to, but Modestly Lower Than, Joe Biden’s 37% Rating in the Summer of 2022
The Impunity Machine. Human Rights Groups say the Israeli Military’s Killing of a Lebanese Journalist was a war Crime. Israel has Faced no Consequences
The Trump Administration Is Losing Its Fight to Take Over Elections
What 100-Plus Federal Actions Reveal About the Trump Administration’s Campaign Against the Press
How Elon Musk Is Re-Engineering the World
Congressional Democrats Launch Probe Into Efforts to Deport U.S. Military Members and Their Families
Radical Reformation. The Catholic Church’s Progressive Revival
A Deep Blue Wave is Rising, and Establishment Democrats are Panicking
“Frankly, if I was Mark Zuckerberg I Would be Absolutely Ecstatic at a Chance to do Something Helpful for Someone in Need and Maybe get Some Good PR out of it”
A Meta Employee Asked for More Time Off. CTO Andrew Bosworth Called the Question ‘Very Dumb’
Trump’s Approval Rating has Declined Over the Course of This Administration. It’s now Comparable to, but Modestly Lower Than, Joe Biden’s 37% Rating in the Summer of 2022
The Impunity Machine. Human Rights Groups say the Israeli Military’s Killing of a Lebanese Journalist was a war Crime. Israel has Faced no Consequences
The Trump Administration Is Losing Its Fight to Take Over Elections
What 100-Plus Federal Actions Reveal About the Trump Administration’s Campaign Against the Press
How Elon Musk Is Re-Engineering the World
Congressional Democrats Launch Probe Into Efforts to Deport U.S. Military Members and Their Families
Radical Reformation. The Catholic Church’s Progressive Revival

Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Sam Raha, president and CEO, will present at the 44^th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 14, at 5:15 pm PT (8:15 pm ET).

The presentation will be available through a live webcast and archived at investor.myriad.com.

About Myriad Genetics 
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact 
Matt Scalo 
(801) 584-3532 
IR@myriad.com 

Media Contact 
Kate Schraml
(224) 875-4493
PR@myriad.com 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.